Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

Por Wählby, Ulrika, Jonsson, E. Niclas, Karlsson, Mats O.
Publicado em 2002

Nonlinearity detection: Advantages of nonlinear mixed-effects modeling

Por Jonsson, E. Niclas, Karlsson, Mats O., Wade, Janet R.
Publicado em 2000

A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children

Por Sjögren, Erik, Tarning, Joel, Barnes, Karen I., Jonsson, E. Niclas
Publicado no Pharmaceutics (2021)

Randomized exposure-controlled trials; impact of randomization and analysis strategies

Por Karlsson, Kristin E, Grahnén, Anders, Karlsson, Mats O, Jonsson, E Niclas
Publicado em 2007

Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain

Por Jonsson, E. Niclas, Xie, Rujia, Marshall, Scott F., Arends, Rosalin H.
Publicado no Br J Clin Pharmacol (2016)

A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children

Por Hamberg, Anna-Karin, Hellman, Jacob, Dahlberg, Jonny, Jonsson, E Niclas, Wadelius, Mia
Publicado no BMC Med Inform Decis Mak (2015)

Population pharmacokinetics of levosimendan in patients with congestive heart failure

Por Jonsson, E Niclas, Antila, Saila, McFadyen, Lynn, Lehtonen, Lasse, Karlsson, Mats O
Publicado em 2003

A Fast Method for Testing Covariates in Population PK/PD Models

Por Khandelwal, Akash, Harling, Kajsa, Jonsson, E. Niclas, Hooker, Andrew C., Karlsson, Mats O.
Publicado em 2011

Characterizing variability in warfarin dose requirements in children using modelling and simulation

Por Hamberg, Anna-Karin, Wadelius, Mia, Friberg, Lena E, Biss, Tina T, Kamali, Farhad, Jonsson, E Niclas
Publicado em 2014

Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients

Por Zingmark, Per-Henrik, Ekblom, Marianne, Odergren, Tomas, Ashwood, Tim, Lyden, Patrick, Karlsson, Mats O, Jonsson, E Niclas
Publicado em 2003

Modeling Disease Progression in Acute Stroke Using Clinical Assessment Scales

Por Karlsson, Kristin E., Wilkins, Justin J., Jonsson, Fredrik, Zingmark, Per-Henrik, Karlsson, Mats O., Jonsson, E. Niclas
Publicado em 2010

Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic–pituitary–gonadal axis following treatment with GnRH analogues

Por Tornøe, Christoffer W, Agersø, Henrik, Senderovitz, Thomas, Nielsen, Henrik A, Madsen, Henrik, Karlsson, Mats O, Jonsson, E Niclas
Publicado em 2007

A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab‐Treated non‐small Cell Lung Cancer Patients

Por Netterberg, Ida, Li, Chi‐Chung, Molinero, Luciana, Budha, Nageshwar, Sukumaran, Siddharth, Stroh, Mark, Jonsson, E. Niclas, Friberg, Lena E.
Publicado no Clin Pharmacol Ther (2018)

Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms

Por Hamberg, Anna-Karin, Friberg, Lena E., Hanséus, Katarina, Ekman-Joelsson, Britt-Marie, Sunnegårdh, Jan, Jonzon, Anders, Lundell, Bo, Jonsson, E. Niclas, Wadelius, Mia
Publicado em 2013

Erratum to: Warfarin dose prediction in children using pharmacometric bridging – comparison with published pharmacogenetic dosing algorithms

Por Hamberg, Anna-Karin, Friberg, Lena E., Hanséus, Katarina, Ekman-Joelsson, Britt-Marie, Sunnegårdh, Jan, Jonzon, Anders, Lundell, Bo, Jonsson, E. Niclas, Wadelius, Mia
Publicado em 2013